Steve MacMillan

Track

Insider profile

Currently holds positions in Hologic Inc and Boston Scientific Corp

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Hologic Inc June 17, 2015 -
Independent Director Boston Scientific Corp April 1, 2015 -
Independent Director Alere Inc Aug. 1, 2013 - July 22, 2015
President, Chief Executive Officer, Director Hologic Inc Dec. 7, 2013 - June 17, 2015
Independent Director Texas Instruments Inc Sept. 18, 2008 - Feb. 17, 2012
Chairman of the Board, President, Chief Executive Officer Stryker Corp Jan. 1, 2010 - Feb. 8, 2012
Steve MacMillan's trades of Hologic Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-23 2025-09-22
US Hologic Inc (HOLX)
PlS Planned sale
39,495 -15.8%
466.68
US$1,913,776 		39,495 -15.8% 466.68 US$1,913,776
2025-09-23 2025-09-22
US Hologic Inc (HOLX)
PlS Planned sale
52,681 -4.4%
14.43
US$304,683 		52,681 -4.4% 14.43 US$304,683
2025-09-23 2025-09-22
US Hologic Inc (HOLX)
PlS Planned sale
34,351 +30.4%
138.43
US$3,443,526 		34,351 +30.4% 138.43 US$3,443,526
2025-09-22 2025-09-22
US Hologic Inc (HOLX)
PrS Proposed sale
138,358
66.98
US$9,266,548 		138,358 66.98 US$9,266,548
2024-08-01 2024-07-30
US Hologic Inc (HOLX)
PlS Planned sale
20,228 -1.7%
82.32
US$1,665,169 		20,228 -1.7% 82.32 US$1,665,169
2024-08-01 2024-07-30
US Hologic Inc (HOLX)
PlS Planned sale
16,177 -1.4%
81.44
US$1,317,455 		16,177 -1.4% 81.44 US$1,317,455
2024-08-01 2024-07-30
US Hologic Inc (HOLX)
PlS Planned sale
7,634 -0.6%
80.60
US$615,300 		7,634 -0.6% 80.60 US$615,300
2024-07-30 2024-07-30
US Hologic Inc (HOLX)
PrS Proposed sale
44,039
81.70
US$3,597,894 		44,039 81.70 US$3,597,894
2024-07-19 2024-07-17
US Hologic Inc (HOLX)
PlS Planned sale
3,672 -0.3%
80.13
US$294,223 		3,672 -0.3% 80.13 US$294,223
2024-07-17 2024-07-17
US Hologic Inc (HOLX)
PrS Proposed sale
3,672
80.13
US$294,222 		3,672 80.13 US$294,222
2023-12-01 2023-11-29
US Hologic Inc (HOLX)
PlS Planned sale
47,711 -3.7%
70.41
US$3,359,188 		47,711 -3.7% 70.41 US$3,359,188
2023-11-29 2023-11-29
US Hologic Inc (HOLX)
PrS Proposed sale
47,711
70.06
US$3,342,633 		47,711 70.06 US$3,342,633
2022-12-02 2022-11-30
US Hologic Inc (HOLX)
S Sale
12,501 -0.5%
76.02
US$950,326 		12,501 -0.5% 76.02 US$950,326
2022-12-02 2022-11-30
US Hologic Inc (HOLX)
S Sale
20,999 -0.9%
75.43
US$1,584,039 		20,999 -0.9% 75.43 US$1,584,039
2022-11-14 2022-11-11
US Hologic Inc (HOLX)
S Sale
42,893 -1.7%
75.94
US$3,257,294 		42,893 -1.7% 75.94 US$3,257,294
2022-11-14 2022-11-11
US Hologic Inc (HOLX)
S Sale
52,529 -2.1%
75.57
US$3,969,564 		52,529 -2.1% 75.57 US$3,969,564
2022-11-14 2022-11-11
US Hologic Inc (HOLX)
S Sale
43,000 -1.7%
75.64
US$3,252,520 		43,000 -1.7% 75.64 US$3,252,520
2020-05-15 2020-05-13
US Hologic Inc (HOLX)
S Sale
190,996 -10.0%
50.97
US$9,735,257 		190,996 -10.0% 50.97 US$9,735,257
2020-02-05 2020-02-03
US Hologic Inc (HOLX)
PlS Planned sale
194,396 -10.3%
53.54
US$10,407,184 		194,396 -10.3% 53.54 US$10,407,184